Please do not adjust margins
RSC Advances
Page 5 of 7
DOI: 10.1039/C6RA11678G
Journal Name
characterized by various spectroscopic analyses. The
ARTICLE
developed catalytic system was also employed at large scale 5,6-dichloro-2-(2-methoxyphenyl)-1H-benzo[d]imidazole (3g):
cyclization reaction with recoverable and reusable properties 1H NMR (400 MHz, DMSO-d6): δ = 12.29 (s, 1H), 8.32-8.27 (m,
without loss of catalytic activity for several cycles in the 1H), 7.90 (s, 1H), 7.78 (s, 1H), 7.50 (t, J = 8.39 Hz, 1H), 7.24 (d, J
synthesis of benzimidazoles. The developed protocol is =8.39 Hz, 1H), 7.11 (t, J =7.63 Hz, 1H), 4.02 (s, 3H); 13C NMR
environmentally benign, does not involve the use of any toxic (100 MHz, DMSO-d6): δ = 156.94, 151.48, 142.40, 134.28,
oxidants and devoid of generation of any toxic/hazardous by- 132.05, 129.88, 124.14, 124.10, 121.00, 119.53, 117.13,
products.
113.22, 112.25, 55.90; ESI-HRMS (m/z) calcd for C14H10Cl2N2O:
293.0243 (MH)+; found: 293.0241 (MH)+.
Experimental
2-(4-butylphenyl)-6-nitro-1H-benzo[d]imidazole (3h):
1H NMR (400 MHz, DMSO-d6): δ = 13.52 (s, 1H), 8.60-8.27 (m,
1H), 8.11 (d, J = 7.63 Hz, 3H), 7.86-7.59 (m, 1H), 7.41 (d, J =
7.63 2H), 2.65 (t, J = 7.63 Hz, 2H), 1.63-1.54 (m, 2H), 1.37-1.27
(m, 2H), 0.90 (t, J = 7.63 Hz, 3H); 13C NMR (100 MHz, DMSO-
d6): δ = 145.78, 142.60, 129.06, 126.97, 126.53, 117.98, 34.72,
32.83, 21.79, 13.78. ESI-HRMS (m/z) calcd for C17H18N3O2:
296.1394 (MH)+; found: 296.1373 (MH)+.
All reagents were purchased from commercial sources and
were used as such. The reaction progress was monitored using
pre-coated TLC plates (E. Merck Kieselgel 60 F254) and spots
were visualised under UV light and also by exposing TLC plates
to iodine vapour. 1H NMR and 13C NMR spectra were recorded
on a JEOL Spectrospin spectrometer at 400 MHz and 100 MHz,
respectively, using TMS as an internal standard. Melting points
were recorded in open capillary tubes on an ERS automated
melting point apparatus and are uncorrected. Mass spectra
were recorded on an Agilent Accurate Mass Q-TOF MS system
or micromass LCT Mass Spectrometer/Data system. IR spectra
were recorded using Bruker FT-IR in the range of 4000–400 cm-
5,6-dichloro-2-(p-tolyl)-1H-benzo[d]imidazole (3i):
1H NMR (400 MHz, DMSO-d6): δ = 13.16 (s, 1H), 8.04 (d, J =
8.39 Hz, 2H), 7.89 (s, 1H), 7.71 (s, 1H), 7.35 (d, J = 7.63 Hz, 2H),
2.36 (s, 3H); 13C NMR (100 MHz, DMSO-d6): δ = 153.97, 140.43,
129.63, 126.68, 126.51, 124.25, 21.01; ESI-HRMS (m/z) calcd
for C14H11Cl2N2: 277.0294 (MH)+; found: 277.0300 (MH)+.
1
and only characteristic frequencies are expressed. CuI
nanoparticles were synthesized as reported previously.40
General procedure for the synthesis of 2-substituted
benzimidazoles
Acknowledgements
A mixture of o-phenylenediamine (1 mmol) and aldehyde (1.1 DSR thanks DST-SERB (File No. EMR/2014/001127) and R & D
mmol) was well stirred with CuI nps (10 mol%) and acetonitrile grant, University of Delhi for the financial support. PLR, MT
(2 mL) at room temperature for appropriate time. At the end and RA thank UGC for the award of senior research fellowship,
of the reaction, as observed by TLC, the reaction mixture was DST for INSPIRE-senior research fellowship and BPCL for their
then diluted with 2-3 mL of EtOAc, and centrifuged to remove encouragement, respectively. We would also like to thank
the catalyst, and the catalyst was further washed with 5-10 mL USIC–CIF, University of Delhi for analytical support.
of EtOAc to make it free from organic matter. To this reaction
mixture, EtOAc (25 mL) was added and washed with water and
Notes and references
then with brine. The organic phase was separated, dried over
sodium sulfate and concentrated under vacuum to get the
crude products. The crude products were purified by silica gel
column chromatography using Hexane:EtOAc (80:20) as
eluent.
1
P. S. Hameed, A. Raichurkar, P. Madhavapeddi, S. Menasinakai,
S. Sharma, P. Kaur, R. Nandishaiah, V. Panduga, J. Reddy, V. K.
Sambandamurthy and D. Sriram, ACS Med. Chem. Lett., 2014,
5, 820-825.
2
3
4
B. Fang, C. H. Zhou and X. C. Rao, Eur. J. Med. Chem., 2010, 45,
4388-4398.
G. Kaur, M. Kaur and O. Silakari, Mini Rev. Med. Chem., 2014,
14, 747-767.
Spectral data for representative compounds
2-(2,6-dichlorophenyl)-1H-benzo[d]imidazole (2g):
1H NMR (400 MHz, DMSO-d6): δ = 12.87 (brs, 1H), 7.72-7.51
(m, 5H), 7.30-7.17 (m, 2H); 13C NMR (100 MHz, DMSO-d6): δ =
146.72, 143.21, 135.08, 134.09, 132.40, 130.61, 128.36,
122.79, 121.60, 119.30, 111.61; anal. calcd for C13H8Cl2N2: C,
59.34; H, 3.06; N, 10.65, found: C, 59.52; H, 3.14; N, 10.55.
T. W. Moore, K. Sana, D. Yan, S. A. Krumm, P. Thepchatri, J. P.
Snyder, J. Marengo, R. F. Arrendale, A. J. Prussia, M. G. Natchus,
D. C. Liotta, R. K. Plemper and A. Sun, ACS Med. Chem. Lett.,
2013, 4, 762-767.
B. Chu, F. Liu, L. Li, C. Ding, K. Chen, Q. Sun, Z. Shen, Y. Tan, C.
Tan and Y. Jiang, Cell Death Dis., 2015, 6, 1686-1695.
M. K. Kim, H. Shin, K. Park, H. Kim, J. Park, K. Kim, J. Nam, H.
Choo and Y. Chong, J. Med. Chem., 2015, 58, 7596-7602.
G. Yadav and S. Ganguly, Eur. J. Med. Chem., 2015, 97, 419-443.
J. B. Wright, Chem. Rev., 1951, 48, 397-541.
5
6
2-(thiophen-2-yl)-1H-benzo[d]imidazole (2n):
1H NMR (400 MHz, DMSO-d6): δ = 12.95 (s, 1H), 7.82 (d, J =
3.05 Hz, 1H), 7.71 (d, J = 5.34 Hz, 1H), 7.63-7.44 (m, 2H), 7.24-
7.12 (m, 3H); 13C NMR (100 MHz, CDCl3): δ = 147.04, 143.66,
134.67, 133.73, 128.75, 128.28, 126.68, 122.39, 121.73,
118.59, 110.99., anal. calcd for C11H8N2S: C, 65.97; H, 4.03; N,
13.99, found: C, 66.08; H, 4.09; N, 13.94.
7
8
9
P. N. Preston, Chem. Rev., 1974, 74, 279-314.
10 M. A. Ibrahim, Heterocycles, 2011, 83, 2689-2730.
This journal is © The Royal Society of Chemistry 20xx
J. Name., 2013, 00, 1-3 | 5
Please do not adjust margins